Anguk Pharmaceutical Acquires Stake in Mirae Asset Anguk New Growth Investment Association No.1 for 13 Billion Won

On October 31, Anguk Pharmaceutical announced that it will acquire 13 million shares of Mirae Asset Anguk New Growth Investment Association No.1 for 13 billion won. The acquisition amount corresponds to 7.89% of its equity capital. Following the acquisition, Anguk Pharmaceutical’s stake in Mirae Asset Anguk New Growth Investment Association No.1 will be 65%. The scheduled date for the share acquisition is October 30, 2029. Anguk Pharmaceutical stated that the purpose of the acquisition is “investment returns.”

This content was produced with the assistance of AI translation services.